CJC-1295 without DAC 5mg + IPA 5mg

What is CJC-1295 No DAC (5mg) / Ipamorelin (5mg)?

CJC-1295 No DAC (5 mg) / Ipamorelin (5 mg) is a dual-peptide research formulation categorized under Muscle Growth & Performance Peptides. It combines two synthetic peptides commonly used in laboratory research to study growth hormone–related signaling and endocrine communication under controlled experimental conditions.

CJC-1295 No DAC, also known as Modified GRF (1-29), is a short-acting peptide fragment derived from growth hormone–releasing hormone (GHRH). Ipamorelin is a selective growth hormone secretagogue peptide studied for its interaction with ghrelin-associated signaling pathways. When used together in research settings, the combination allows investigators to examine complementary peptide signaling mechanisms without the prolonged binding effects associated with DAC-modified peptides.

This formulation is intended strictly for laboratory research use and is supplied in a standardized, lyophilized format to support reproducibility and consistency across experimental workflows.

Product Specifications

• CAS Numbers:
  • CJC-1295 No DAC: 863288-34-0
  • Ipamorelin: 170851-70-4
• Peptide Sequences:
  • CJC-1295 No DAC (MOD-GRF 1-29):
    Tyr–D-Ala–Asp–Ala–Ile–Phe–Thr–Gln–Ser–Tyr–Arg–Lys–Val–Leu–Ala–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Leu–Ser–Arg
  • Ipamorelin:
    Aib–His–D-2-Nal–D-Phe–Lys–NH₂
• Purity: Typically ≥95% (verified by HPLC and mass spectrometry)
• Packaging Format: Lyophilized powder, combined total of 10 mg per vial (5 mg each peptide)
• Storage Conditions: Store at −20 °C; protect from light and moisture

Key Characteristics of CJC-1295 No DAC (5mg) / Ipamorelin (5mg)

• Dual-peptide formulation designed for controlled laboratory research
• Synthetic peptides manufactured for batch consistency and reproducibility
• Lyophilized presentation supports stability during storage and handling
• Frequently used in endocrine and metabolic signaling research models
• Verified using standard analytical methods such as HPLC and MS
• Compatible with standard peptide handling and storage protocols

How CJC-1295 No DAC (5mg) / Ipamorelin (5mg) Supports Research

In laboratory studies, CJC-1295 No DAC and Ipamorelin are used to explore growth hormone–related signaling through distinct but complementary pathways. CJC-1295 No DAC is studied for its interaction with GHRH-associated mechanisms, while Ipamorelin is examined for its selective engagement with ghrelin-related receptors. Together, they allow researchers to investigate coordinated peptide signaling responses in endocrine and metabolic research models.